Camp4 Therapeutics Corporation · NASDAQ:CAMP

Enavate Sciences Gp, LLC reported a 6.00% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)

Event Dec 19, 2025 · Filed Dec 23, 2025

Enavate Sciences Gp, LLC reported a 6.00% stake in Camp4 Therapeutics Corporation, 3,127,360 shares, with active intent on Dec 19, 2025. Filed Dec 23, 2025 (Schedule 13D/A).

Stake
6.00%
Shares
3,127,360
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Enavate Sciences GP, LLC6.00%3,127,360
Everest Aggregator, LP6.00%3,127,360

Source

View original at SEC

Related